跳至主要内容
临床试验/NL-OMON21254
NL-OMON21254招募中不适用

Multicenter pilot study to determine the feasibility of a multimodal prehabilitation program in patients with non-small cell lung cancer undergoing anatomical lung resection

MMC0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
MMC
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • - =18 years of age
  • - NSCLC, pathologically confirmed or high suspicion of NSCLC, with an indication for anatomical lung resection
  • - Eligible for anatomical lung resection, that will be performed in MMC or ASz
  • - Straight forward preoperative work-up, with confirmation of eligibility for surgery by lung surgeon before the MDT meeting
  • - Written informed consent

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • - Inability to give written informed consent (illiteracy, language barrier, cognitive disabilities)
  • - Contra-indication for training (e.g. comorbid conditions, signs of undiagnosed cardiac disease, physical or psychological impairments)
  • - Renal insufficiency, defined as estimated Glomerular Filtration Rate (eGFR) <60 ml/min/1.73m2 (estimated using the Modification of Diet in Renal Disease (MDRD) formula in the MMC and estimated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula in the ASz)
  • - Participation in MEDIAST trial (NTR6528; NL60692.015.17)
  • - In case of patients in ASz: referral by pulmonologist from Beatrix hospital, Gorinchem (the Netherlands) for surgery in ASz

研究者

发起方
MMC

相似试验